ArticleBiomedicines2025

Efficacy and Safety of Topical 5% Cannabidiol Plus Myrcene for the Treatment of Vestibulodynia: A Multi-Centric Randomized Controlled Trial.

Filippo Murina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.